Copyright Reports & Markets. All rights reserved.

Global Microbiome Therapies Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Microbiome Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Bacteria
    • 1.2.3 Fungi
    • 1.2.4 Virus
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Microbiome Therapies Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Testing Centres
    • 1.3.3 Research Labs
    • 1.3.4 Horticulture
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Microbiome Therapies Market Perspective (2016-2027)
  • 2.2 Microbiome Therapies Growth Trends by Regions
    • 2.2.1 Microbiome Therapies Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Microbiome Therapies Historic Market Share by Regions (2016-2021)
    • 2.2.3 Microbiome Therapies Forecasted Market Size by Regions (2022-2027)
  • 2.3 Microbiome Therapies Industry Dynamic
    • 2.3.1 Microbiome Therapies Market Trends
    • 2.3.2 Microbiome Therapies Market Drivers
    • 2.3.3 Microbiome Therapies Market Challenges
    • 2.3.4 Microbiome Therapies Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Microbiome Therapies Players by Revenue
    • 3.1.1 Global Top Microbiome Therapies Players by Revenue (2016-2021)
    • 3.1.2 Global Microbiome Therapies Revenue Market Share by Players (2016-2021)
  • 3.2 Global Microbiome Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Microbiome Therapies Revenue
  • 3.4 Global Microbiome Therapies Market Concentration Ratio
    • 3.4.1 Global Microbiome Therapies Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapies Revenue in 2020
  • 3.5 Microbiome Therapies Key Players Head office and Area Served
  • 3.6 Key Players Microbiome Therapies Product Solution and Service
  • 3.7 Date of Enter into Microbiome Therapies Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Microbiome Therapies Breakdown Data by Type

  • 4.1 Global Microbiome Therapies Historic Market Size by Type (2016-2021)
  • 4.2 Global Microbiome Therapies Forecasted Market Size by Type (2022-2027)

5 Microbiome Therapies Breakdown Data by Application

  • 5.1 Global Microbiome Therapies Historic Market Size by Application (2016-2021)
  • 5.2 Global Microbiome Therapies Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Microbiome Therapies Market Size (2016-2027)
  • 6.2 North America Microbiome Therapies Market Size by Type
    • 6.2.1 North America Microbiome Therapies Market Size by Type (2016-2021)
    • 6.2.2 North America Microbiome Therapies Market Size by Type (2022-2027)
    • 6.2.3 North America Microbiome Therapies Market Size by Type (2016-2027)
  • 6.3 North America Microbiome Therapies Market Size by Application
    • 6.3.1 North America Microbiome Therapies Market Size by Application (2016-2021)
    • 6.3.2 North America Microbiome Therapies Market Size by Application (2022-2027)
    • 6.3.3 North America Microbiome Therapies Market Size by Application (2016-2027)
  • 6.4 North America Microbiome Therapies Market Size by Country
    • 6.4.1 North America Microbiome Therapies Market Size by Country (2016-2021)
    • 6.4.2 North America Microbiome Therapies Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Microbiome Therapies Market Size (2016-2027)
  • 7.2 Europe Microbiome Therapies Market Size by Type
    • 7.2.1 Europe Microbiome Therapies Market Size by Type (2016-2021)
    • 7.2.2 Europe Microbiome Therapies Market Size by Type (2022-2027)
    • 7.2.3 Europe Microbiome Therapies Market Size by Type (2016-2027)
  • 7.3 Europe Microbiome Therapies Market Size by Application
    • 7.3.1 Europe Microbiome Therapies Market Size by Application (2016-2021)
    • 7.3.2 Europe Microbiome Therapies Market Size by Application (2022-2027)
    • 7.3.3 Europe Microbiome Therapies Market Size by Application (2016-2027)
  • 7.4 Europe Microbiome Therapies Market Size by Country
    • 7.4.1 Europe Microbiome Therapies Market Size by Country (2016-2021)
    • 7.4.2 Europe Microbiome Therapies Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Microbiome Therapies Market Size (2016-2027)
  • 8.2 Asia-Pacific Microbiome Therapies Market Size by Type
    • 8.2.1 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Microbiome Therapies Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Microbiome Therapies Market Size by Application
    • 8.3.1 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Microbiome Therapies Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Microbiome Therapies Market Size by Region
    • 8.4.1 Asia-Pacific Microbiome Therapies Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Microbiome Therapies Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Microbiome Therapies Market Size (2016-2027)
  • 9.2 Latin America Microbiome Therapies Market Size by Type
    • 9.2.1 Latin America Microbiome Therapies Market Size by Type (2016-2021)
    • 9.2.2 Latin America Microbiome Therapies Market Size by Type (2022-2027)
    • 9.2.3 Latin America Microbiome Therapies Market Size by Type (2016-2027)
  • 9.3 Latin America Microbiome Therapies Market Size by Application
    • 9.3.1 Latin America Microbiome Therapies Market Size by Application (2016-2021)
    • 9.3.2 Latin America Microbiome Therapies Market Size by Application (2022-2027)
    • 9.3.3 Latin America Microbiome Therapies Market Size by Application (2016-2027)
  • 9.4 Latin America Microbiome Therapies Market Size by Country
    • 9.4.1 Latin America Microbiome Therapies Market Size by Country (2016-2021)
    • 9.4.2 Latin America Microbiome Therapies Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Microbiome Therapies Market Size (2016-2027)
  • 10.2 Middle East & Africa Microbiome Therapies Market Size by Type
    • 10.2.1 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Microbiome Therapies Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Microbiome Therapies Market Size by Application
    • 10.3.1 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Microbiome Therapies Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Microbiome Therapies Market Size by Country
    • 10.4.1 Middle East & Africa Microbiome Therapies Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Microbiome Therapies Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 uBiome
    • 11.1.1 uBiome Company Details
    • 11.1.2 uBiome Business Overview
    • 11.1.3 uBiome Microbiome Therapies Introduction
    • 11.1.4 uBiome Revenue in Microbiome Therapies Business (2016-2021)
    • 11.1.5 uBiome Recent Development
  • 11.2 Evolve BioSystems
    • 11.2.1 Evolve BioSystems Company Details
    • 11.2.2 Evolve BioSystems Business Overview
    • 11.2.3 Evolve BioSystems Microbiome Therapies Introduction
    • 11.2.4 Evolve BioSystems Revenue in Microbiome Therapies Business (2016-2021)
    • 11.2.5 Evolve BioSystems Recent Development
  • 11.3 Indigo Agriculture
    • 11.3.1 Indigo Agriculture Company Details
    • 11.3.2 Indigo Agriculture Business Overview
    • 11.3.3 Indigo Agriculture Microbiome Therapies Introduction
    • 11.3.4 Indigo Agriculture Revenue in Microbiome Therapies Business (2016-2021)
    • 11.3.5 Indigo Agriculture Recent Development
  • 11.4 Pivot Bio
    • 11.4.1 Pivot Bio Company Details
    • 11.4.2 Pivot Bio Business Overview
    • 11.4.3 Pivot Bio Microbiome Therapies Introduction
    • 11.4.4 Pivot Bio Revenue in Microbiome Therapies Business (2016-2021)
    • 11.4.5 Pivot Bio Recent Development
  • 11.5 Concentric Ag
    • 11.5.1 Concentric Ag Company Details
    • 11.5.2 Concentric Ag Business Overview
    • 11.5.3 Concentric Ag Microbiome Therapies Introduction
    • 11.5.4 Concentric Ag Revenue in Microbiome Therapies Business (2016-2021)
    • 11.5.5 Concentric Ag Recent Development
  • 11.6 Epibiome
    • 11.6.1 Epibiome Company Details
    • 11.6.2 Epibiome Business Overview
    • 11.6.3 Epibiome Microbiome Therapies Introduction
    • 11.6.4 Epibiome Revenue in Microbiome Therapies Business (2016-2021)
    • 11.6.5 Epibiome Recent Development
  • 11.7 CosmosID
    • 11.7.1 CosmosID Company Details
    • 11.7.2 CosmosID Business Overview
    • 11.7.3 CosmosID Microbiome Therapies Introduction
    • 11.7.4 CosmosID Revenue in Microbiome Therapies Business (2016-2021)
    • 11.7.5 CosmosID Recent Development
  • 11.8 Human Longevity
    • 11.8.1 Human Longevity Company Details
    • 11.8.2 Human Longevity Business Overview
    • 11.8.3 Human Longevity Microbiome Therapies Introduction
    • 11.8.4 Human Longevity Revenue in Microbiome Therapies Business (2016-2021)
    • 11.8.5 Human Longevity Recent Development
  • 11.9 Ajinomoto Cambrooke
    • 11.9.1 Ajinomoto Cambrooke Company Details
    • 11.9.2 Ajinomoto Cambrooke Business Overview
    • 11.9.3 Ajinomoto Cambrooke Microbiome Therapies Introduction
    • 11.9.4 Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2016-2021)
    • 11.9.5 Ajinomoto Cambrooke Recent Development
  • 11.10 AnimalBiome
    • 11.10.1 AnimalBiome Company Details
    • 11.10.2 AnimalBiome Business Overview
    • 11.10.3 AnimalBiome Microbiome Therapies Introduction
    • 11.10.4 AnimalBiome Revenue in Microbiome Therapies Business (2016-2021)
    • 11.10.5 AnimalBiome Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Microbiome Therapies Scope and Market Size
    Microbiome Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microbiome Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Bacteria
    Fungi
    Virus
    Others

    Segment by Application
    Testing Centres
    Research Labs
    Horticulture
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    uBiome
    Evolve BioSystems
    Indigo Agriculture
    Pivot Bio
    Concentric Ag
    Epibiome
    CosmosID
    Human Longevity
    Ajinomoto Cambrooke
    AnimalBiome

    Buy now